Drugs Made In America Acquisition II Corp. (DMII)
10.22
+0.02
(+0.15%)
USD |
NASDAQ |
Nov 04, 16:00
Drugs Made In America Acquisition II Shareholders Equity (Quarterly) : 495.96M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 495.96M |
| March 31, 2026 | 491.56M |
| December 31, 2025 | 487.16M |
| Date | Value |
|---|---|
| September 30, 2025 | 482.83M |
| June 30, 2025 | -0.2141M |
| March 31, 2025 | -0.176M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Acme United Corp. | 124.87M |
| American Shared Hospital Services | 23.11M |
| Avalon Holdings Corp. | 38.00M |
| Flanigan's Enterprises, Inc. | 69.76M |
| Bar Harbor Bankshares | 535.61M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 514.10M |
| Total Liabilities (Quarterly) | 18.14M |
| Debt to Equity Ratio | 0.0009 |
| Current Ratio | 0.3379 |
| Net Debt Paydown Yield | -0.01% |